Hot Investor Mandate: Venture Firm with Europe and Asia Offices Invest in Life Science & Healthcare Technologies Addressing Prevention and Treatment of Chronic Diseases

4 Apr

A venture firm with offices in Europe and Asia invests in life science companies in the Benelux region, Germany, France, and parts of Asia, all near where the firm has operations. The firm may invest up to EUR 10 million in early stage venture rounds as well as clinical stage opportunities.

The firm invests in the prevention and treatment of chronic diseases. In terms of sector, the firm makes investments in therapeutics, medtech and digital health and diagnostics. Generally the firm invests in assets that are close to IND or close to registration for first in human trials.

The firm is interested in opportunities with a driven entrepreneurial team, good IP protection, which are addressing important medical needs.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: